Comparison of efficacy of add-on therapy of teneligliptin versus pioglitazone among type 2 diabetes mellitus patients ineptly controlled on dual therapy of metformin plus sulfonylurea
Author(s) -
VanjariNikhil Kumar,
SandeepReddy Konyala,
SivaSubrahmanyam Bandaru,
Goverdhan Puchchakayala
Publication year - 2019
Publication title -
journal of diabetology
Language(s) - English
Resource type - Journals
eISSN - 2543-3288
pISSN - 2078-7685
DOI - 10.4103/jod.jod_24_18
Subject(s) - pioglitazone , medicine , metformin , sulfonylurea , type 2 diabetes mellitus , type 2 diabetes , gastroenterology , diabetes mellitus , combination therapy , clinical endpoint , insulin , endocrinology , randomized controlled trial
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom